The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC

Table 1

General characteristics of ESCC patients.

Clinical characteristics	(%)
Age (years)
<60	70 (40.7%)
≥60	102 (59.3%)
Gender
Male	118 (68.6%)
Female	54 (31.4%)
Ethnicity
Han	58 (33.7%)
Kazakh	114 (66.3%)
Tumor location
Upper	6 (3.5%)
Middle	96 (55.8%)
Lower	70 (40.7%)
Tumor size(cm)
<3	51 (29.7%)
≥3	121 (70.3%)
Differentiation
Poor	61 (21.3%)
Moderate	123 (53.0%)
Well	48(20.7%)
Lymph metastasis
Negative	121 (70.3%)
Positive	51 (29.7%)
Invasive depth
Mucosa	5 (2.9%)
Muscularis	78 (45.3%)
Full thickness	89 (51.7%)
AJCC stage
IA+B	13 (7.6%)
IIA+B	113 (65.7%)
IIIA+B	32 (18.6%)
IVA+B	14 (8.1%)
Vascular invasion
Negative	141 (82%)
Positive	31 (18.0%)
Nerve invasion
Negative	135 (78.5%)
Positive	37 (21.5%)
Hematogenous metastasis
Negative	146 (84.9%)
Positive	26 (15.1%)
Radiochemotherapy
Yes	62 (36.0%)
No	110 (64.0%)

Abbreviations: ESCC: esophageal squamous cell carcinoma; AJCC: American Joint Committee on Cancer.